This finding is important to note since the dominating CD4/CD8 T-cell component within the mpc-PTLD group has been associated with EBV infection status due to the naturally occurring T-cell immune response seen in EBV positive immunocompetent patients (8, 46). Here, CD8A is linked to post-transplant lymphoproliferative disease.